EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
92 hedge funds and large institutions have $151M invested in Eiger BioPharmaceuticals, Inc. in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 35 increasing their positions, 18 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
23% less capital invested
Capital invested by funds: $196M → $151M (-$45.3M)
Holders
92
Holding in Top 10
2
Calls
$1.06M
Puts
$599K
Top Buyers
| 1 | +$2.64M | |
| 2 | +$1.5M | |
| 3 | +$679K | |
| 4 |
Renaissance Technologies
New York
|
+$663K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$456K |
Top Sellers
| 1 | -$8.83M | |
| 2 | -$2.43M | |
| 3 | -$621K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$511K |
| 5 |
Two Sigma Advisers
New York
|
-$434K |